Haemophilia, 1351-8216

Journal

More filtering options
  1. 2018
  2. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII

    Hermans, C., Mahlangu, J., Booth, J., Schütz, H., Santagostino, E., Young, G., Lee, H. Y., Steinitz-Trost, K. N., Blanchette, V. & E. Berntorp, 2018 May 6, In : Haemophilia.

    Research output: Contribution to journalArticle

  3. Fifth Åland Island conference on von Willebrand disease

    E. Berntorp, Ågren, A., Aledort, L., Blombäck, M., Cnossen, M. H., Croteau, S. E., von Depka, M., Federici, A. B., Goodeve, A., Goudemand, J., Mannucci, P. M., Mourik, M., Önundarson, P. T., Rodeghiero, F., Szántó, T. & Windyga, J., 2018 May 1, In : Haemophilia. 24, p. 5-19 15 p.

    Research output: Contribution to journalArticle

  4. Replacement therapy during surgery in von Willebrand disease needs personalization

    E. Berntorp, 2018 May 1, In : Haemophilia. 24, 3, p. 338-340 3 p.

    Research output: Contribution to journalDebate/Note/Editorial

  5. The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia

    Strandberg, K. & J. Astermark, 2018 May 1, In : Haemophilia. 24, p. 9-14 6 p.

    Research output: Contribution to journalArticle

  6. Immune tolerance induction: What have we learned over time?

    Brackmann, H. H., White, G. C., E. Berntorp, Andersen, T. & Escuriola-Ettingshausen, C., 2018 Apr 1, In : Haemophilia. 24, p. 3-14 12 p.

    Research output: Contribution to journalReview article

  7. Defining extended half-life rFVIII-A critical review of the evidence

    Mahlangu, J., Young, G., Hermans, C., Blanchette, V., E. Berntorp & Santagostino, E., 2018 Jan 1, In : Haemophilia.

    Research output: Contribution to journalArticle

  8. Evaluation of prophylactic therapy in haemophilia with global coagulation tests

    E. Zetterberg, Brolin, K., Lindahl, R., Knobe, K. & E. Berntorp, 2018 Jan 1, In : Haemophilia. 24, 1, p. e10-e13

    Research output: Contribution to journalLetter

  9. 2017
  10. Preference-based valuation of treatment attributes in haemophilia A using web survey

    K. Steen Carlsson, Andersson, E. & E. Berntorp, 2017 Nov 1, In : Haemophilia. 23, 6, p. 894-903 10 p.

    Research output: Contribution to journalArticle

  11. The impact of clinical practice on the outcome of central venous access devices in children with haemophilia

    Khair, K., Ranta, S., Thomas, A. & Lindvall, K., 2017 Jul 1, In : Haemophilia. 23, 4, p. e276-e281

    Research output: Contribution to journalArticle

  12. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden

    M Osooli, Lövdahl, S., K Steen Carlsson, Knobe, K., Baghaei, F., Holmström, M., J Astermark & E Berntorp, 2017 Mar, In : Haemophilia. 23, 2, p. e79-e86

    Research output: Contribution to journalArticle

  13. European retrospective study of real-life haemophilia treatment

    E. Berntorp, Dolan, G., Hay, C., Linari, S., Santagostino, E., Tosetto, A., Castaman, G., Álvarez-Román, M., Parra Lopez, R., Oldenburg, J., Albert, T., Scholz, U., Holmström, M., Schved, J. F., Trossaërt, M., Hermans, C., Boban, A., Ludlam, C. & Lethagen, S., 2017 Jan, In : Haemophilia. 23, 1, p. 105-114

    Research output: Contribution to journalArticle

  14. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

    Kahle, J., Orlowski, A., Stichel, D., Healey, J. F., Parker, E. T., Donfield, S. M., J. Astermark, E. Berntorp, Lollar, P., Schwabe, D. & Königs, C., 2017, In : Haemophilia. 23, 2, p. 292-299

    Research output: Contribution to journalArticle

  15. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

    K. Kihlberg, Strandberg, K., Rosén, S., R. Ljung & J. Astermark, 2017, In : Haemophilia. 23, 4, p. 620-627

    Research output: Contribution to journalArticle

  16. Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay

    Ljungkvist, M., Lövdahl, S., E. Zetterberg & E. Berntorp, 2017, In : Haemophilia. 23, 3, p. e214-e218

    Research output: Contribution to journalArticle

  17. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: A two-centre study

    A. Hillarp, Bowyer, A. E., Ezban, M., Persson, P. & Kitchen, S., 2017, In : Haemophilia. 23, 3, p. 458-465

    Research output: Contribution to journalArticle

  18. Plasma products do not solve the inhibitor problem

    van den Berg, H. M., Pipe, S. & R. Ljung, 2017, In : Haemophilia. 23, 3, p. 346-347

    Research output: Contribution to journalDebate/Note/Editorial

  19. The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register

    M Osooli, K Steen Carlsson, Baghaei, F., Holmström, M., Rauchensteiner, S., Holme, P. A., Hvitfeldt, L., J Astermark & E Berntorp, 2017, In : Haemophilia. 23, 3, p. e180-e187

    Research output: Contribution to journalArticle

  20. 2016
  21. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    Vepsäläinen, K., Lassila, R., Arola, M., Huttunen, P., Koskinen, S., R. Ljung, Lähteenmäki, P., Möttönen, M. & Riikonen, P., 2016 Sep 1, In : Haemophilia. 22, 5, p. 721-729 9 p.

    Research output: Contribution to journalArticle

  22. Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores

    Oldenburg, J., Zimmermann, R., Katsarou, O., Zanon, E., Kellermann, E., B. Lundin & Ellinghaus, P., 2016 Sep 1, In : Haemophilia. 22, 5, p. 760-764 5 p.

    Research output: Contribution to journalArticle

  23. Haemophilia treatment in 2030

    E. Berntorp, 2016 Jul 1, In : Haemophilia. 22, S5, p. 15-19 5 p.

    Research output: Contribution to journalArticle

  24. Phenotype and genotype comparisons in carriers of haemophilia A

    Olsson, A., R Ljung, Hellgren, M., E Berntorp & Baghaei, F., 2016 May, In : Haemophilia. 22, 3, p. 235–237

    Research output: Contribution to journalArticle

  25. Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe

    Holme, P. A., Combescure, C., Tait, R. C., E. Berntorp, Rauchensteiner, S. & de Moerloose, P., 2016 Mar 1, In : Haemophilia. 22, 2, p. 248-255 8 p.

    Research output: Contribution to journalArticle

  26. Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.

    Valentino, L. A., Pipe, S. W., Collins, P. W., Blanchette, V. S., Erik Berntorp, Fischer, K., Ewenstein, B. M., Oh, M. & Spotts, G., 2016, In : Haemophilia. 22, 4, p. 514-20

    Research output: Contribution to journalArticle

  27. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Rolf Ljung, Kenet, G., Mancuso, M. E., Kaleva, V., Rusen, L., Tseneklidou-Stoeter, D., Michaels, L. A., Shah, A., Hong, W. & Maas Enriquez, M., 2016, In : Haemophilia. 22, 3, p. 354-360

    Research output: Contribution to journalArticle

  28. Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.

    Erik Berntorp, Negrier, C., Gozzi, P., Blaas, P-M. & Lethagen, S., 2016, In : Haemophilia.

    Research output: Contribution to journalArticle

  29. Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

    Fischer, K., Nijdam, A., Holmström, M., Petrini, P., Rolf Ljung, van der Schouw, Y. T. & Berntorp, E., 2016, In : Haemophilia.

    Research output: Contribution to journalArticle

  30. 2015
  31. Acute effects of exercise on specific and global coagulation parameters in severe haemophilia A.

    Olofsson, H. E., Lövdahl, S., Ola Thorsson, Erik Berntorp & Eva Zetterberg, 2015, In : Haemophilia. 21, 5, p. E416-E419

    Research output: Contribution to journalLetter

  32. Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophilia.

    Olsson, A., Hellgren, M., Erik Berntorp & Baghaei, F., 2015, In : Haemophilia. 21, 6, p. 742-746

    Research output: Contribution to journalArticle

  33. Bleeding phenotype in carriers of haemophilia A does not correlate with thrombin generation

    Olsson, A., Hellgren, M., Erik Berntorp, Holmstrom, M. & Baghaei, F., 2015, In : Haemophilia. 21, 1, p. E111-E113

    Research output: Contribution to journalLetter

  34. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.

    Andreas Hillarp, Friedman, K. D., Adcock-Funk, D., Tiefenbacher, S., Nichols, W. L., Chen, D., Stadler, M. & Schwartz, B. A., 2015, In : Haemophilia. 21, 6, p. 837-845

    Research output: Contribution to journalArticle

  35. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand

    Oldenburg, J., Zimmermann, R., Katsarou, O., Theodossiades, G., Zanon, E., Niemann, B., Kellermann, E. & Björn Lundin, 2015, In : Haemophilia. 21, 2, p. 171-179

    Research output: Contribution to journalArticle

  36. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access

    Nijdam, A., Kurnik, K., Liesner, R., Rolf Ljung, Nolan, B., Petrini, P. & Fischer, K., 2015, In : Haemophilia. 21, 4, p. 444-450

    Research output: Contribution to journalArticle

  37. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.

    Annika Mårtensson, Letelier, A., Halldén, C. & Rolf Ljung, 2015, In : Haemophilia.

    Research output: Contribution to journalArticle

  38. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease

    Makris, M., Federici, A. B., Mannucci, P. M., Bolton-Maggs, P. H. B., Yee, T. T., Abshire, T. & Erik Berntorp, 2015, In : Haemophilia. 21, 3, p. 338-342

    Research output: Contribution to journalArticle

  39. 2014
  40. Similar bleeding phenotype in young children with haemophilia A or B: A cohort study

    Rodin Study group, 2014 Nov 1, In : Haemophilia. 20, 6, p. 747-755 9 p.

    Research output: Contribution to journalArticle

  41. A longitudinal study of family structure in Swedish persons with haemophilia.

    Lövdahl, S., Henriksson, K. M., Baghaei, F., Holmström, M., Erik Berntorp & Jan Astermark, 2014, In : Haemophilia. 20, 4, p. 493-499

    Research output: Contribution to journalArticle

  42. Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis

    Castaman, G., Andreas Hillarp & Goodeve, A., 2014, In : Haemophilia. 20, p. 65-70

    Research output: Contribution to journalReview article

  43. Managing Haemophilia for Life: 4th Haemophilia Global Summit

    Jan Astermark, Dolan, G., Hilberg, T., Jimenez-Yuste, V., Laffan, M., Lassila, R., Lobet, S., Martinoli, C. & Perno, C. -F., 2014, In : Haemophilia. 20, p. 1-20

    Research output: Contribution to journalReview article

  44. Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance?

    Erik Berntorp, Dolan, G., Hermans, C., Laffan, M., Santagostino, E. & Tiede, A., 2014, In : Haemophilia. 20, p. 1-11

    Research output: Contribution to journalArticle

  45. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry

    Fischer, K., Rolf Ljung, Platokouki, H., Liesner, R., Claeyssens, S., Smink, E. & Van den Berg, H. M., 2014, In : Haemophilia. 20, 4, p. e280-e286

    Research output: Contribution to journalArticle

  46. Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity

    Matino, D., Lillicrap, D., Jan Astermark, Dolan, G., Kessler, C., Lambert, T., Makris, M., O'Donnell, J., Pipe, S., Santagostino, E., Saint-Remy, J. -M., Schramm, W. & Iorio, A., 2014, In : Haemophilia. 20, 2, p. 200-206

    Research output: Contribution to journalArticle

  47. 2013
  48. F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

    Schwarz, J., Jan Astermark, Menius, E. D., Carrington, M., Donfield, S. M., Gomperts, E. D., Nelson, G. W., Oldenburg, J., Pavlova, A., Shapiro, A. D., Winkler, C. A. & Erik Berntorp, 2013, In : Haemophilia. 19, 1, p. 113-118

    Research output: Contribution to journalArticle

  49. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

    Gringeri, A., Leissinger, C., Cortesi, P. A., Jo, H., Fusco, F., Riva, S., Antmen, B., Erik Berntorp, Biasoli, C., Carpenter, S., Kavakli, K., Morfini, M., Negrier, C., Rocino, A., Schramm, W., Windyga, J., Zulfikar, B. & Mantovani, L. G., 2013, In : Haemophilia. 19, 5, p. 736-743

    Research output: Contribution to journalArticle

  50. History of prophylaxis.

    Erik Berntorp, 2013, In : Haemophilia. 19, 2, p. 163-165

    Research output: Contribution to journalArticle

  51. Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.

    Lövdahl, S., Henriksson, M., Baghaei, F., Holmström, E. M., Nilsson, J-Å., Erik Berntorp & Jan Astermark, 2013, In : Haemophilia. 19, 3, p. 362-369

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 Next